Medtronic (MDT) Tops Q3 EPS by 1c; Reiterates Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Medtronic, Inc. (MDT) PT Raised to $87 at Oppenheimer Following 3Q Report
February 22, 2017 9:23 AM ESTOppenheimer raised its price target on Medtronic, Inc. (NYSE: MDT) to $87.00 (from $84.00) while maintaining a Outperform rating.
Analyst Steven Lichtman commented, "MDT's F3Q sales (+6% cc) came in ahead, with each major segment coming in slightly above our thinking, and growth evenly split... More
Wedbush Maintains Neutral Rating and $85 PT on Medtronic (MDT) Following F3Q17 Results
February 22, 2017 7:52 AM ESTWedbush Securities analyst Tao Levy reiterates Neutral rating and $85 price target on Medtronic Plc (NYSE: MDT), suggesting solid results demonstrate recovery from last quarters disruptions, as the company reported fiscal 2017 third quarter revenues above consensus estimates.
Levy comments, "Medtronics broad product portfolio allows the company to... More
Medtronic, Inc. (MDT) PT Raised to $91 at Needham & Company
February 21, 2017 1:38 PM ESTNeedham & Company raised its price target on Medtronic, Inc. (NYSE: MDT) to $91.00 (from $84.00) while maintaining a Buy rating. 3Q revenue was $7.283B vs. consensus estimates of $7.221B and adjusted EPS was $1.12 vs. consensus of $1.11.
Analyst Mike Matson commented, "F3Q17 revenue and... More
Medtronic, Inc. (MDT) PT Raised to $88 at Evercore ISI
February 21, 2017 11:50 AM ESTEvercore ISI raised its price target on Medtronic, Inc. (NYSE: MDT) to $88.00 (from $78.00) while maintaining a Buy rating following results this morning.
Analyst Vijay Kumar commented, "MDT started 2017 with a solid execution, highlighted by all around revenue beat and operating margins that were generally in line with ST (came in above us). The importance of this Q cannot be underestimated in our mind, as sentiment had turned negative (post a disappointing 1H) and the stock... More
